United States · FDA National Drug Code directory

Ligatend Liquescence

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
83027-0036_172634c8-cf5f-4fb0-ba51-c8240a5ca858
Product NDC
83027-0036
Form
LIQUID
Composition / generic term
Hypericum Perforatum, Ruta Graveolens, Arnica Montana, Bryonia (Alba), Chondroitin Sulfate, Collagen, Eupatorium Perfoliatum, Medulla Ossis Suis, Rhus Tox, Manganum Metallicum, Magnesium Metallicum
Labeler
Nutritional Specialties, Inc.
Marketing category
UNAPPROVED HOMEOPATHIC
Marketing start / end (source format)
20230421 / 20290126

Source-listed ingredients

  • HYPERICUM PERFORATUM WHOLE — 3 [hp_X]/mL
  • RUTA GRAVEOLENS FLOWERING TOP — 3 [hp_X]/mL
  • ARNICA MONTANA WHOLE — 6 [hp_X]/mL
  • BRYONIA ALBA ROOT — 6 [hp_X]/mL
  • CHONDROITIN SULFATE (BOVINE) — 6 [hp_X]/mL
  • HYDROLYSED BOVINE COLLAGEN (ENZYMATIC — 6 [hp_X]/mL
  • 3500 MW) — 6 [hp_X]/mL
  • EUPATORIUM PERFOLIATUM FLOWERING TOP — 6 [hp_X]/mL
  • SUS SCROFA BONE MARROW — 6 [hp_X]/mL
  • TOXICODENDRON PUBESCENS LEAF — 12 [hp_X]/mL
  • MANGANESE — 15 [hp_X]/mL
  • MAGNESIUM

These values do not establish equivalence or a dose recommendation.

Packages

  • 120 mL in 1 BOTTLE, GLASS (83027-0036-1) · 83027-0036-1

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →